Consolidated Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Cash flows from operating activities:
Net loss	$ (1,994,586)	$ (1,440,529)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	1,985	2,001
Amortization of intangibles	17,455	9,681
Stock based compensation	330,787	313,505
Employees paid in stock	293,551	264,953
Expense paid in stock	0	66,061
Unrealized gain on marketable securities	0	(27,890)
Amortization of right-of-use asset	25,875	24,466
Changes in operating assets and liabilities:
Increase in accounts receivable	(43,171)	(349,173)
Increase in accounts receivable, related parties	(6,423)
Increase in inventories	(446,281)	(221,843)
Decrease (increase) in advances on contracts	331,520	(49,571)
Increase in prepaid expenses and other current assets	(185,688)	(345,804)
Increase in accounts payable	896,908	415,974
Increase in accounts payable, related party	267,575	378,807
Decrease in accrued expenses	(480,382)	(270,310)
Increase in accrued expenses, related party	7,448	33,532
Decrease operating right of use lease asset	(24,662)	(21,988)
Net cash used in operating activities	(1,008,089)	(1,218,128)
Cash flows from investing activities:
Purchase of furniture, fixtures, and equipment	(1,304)
Sale of marketable securities	0	2,004,463
Net cash (used in) provided by investing activities	(1,304)	2,004,463
Cash flows from financing activities:
Net Proceeds exercise of warrants	0	51,751
Payments finance lease obligations	(2,278)	(2,478)
Net cash (used in) provided by financing activities	(2,278)	241,429
Net (decrease) increase in cash and cash equivalents	(1,011,671)	1,027,764
Cash and cash equivalents at beginning of period	3,258,058	2,977,713
Cash and cash equivalents at end of period	2,246,387	4,005,477
Public Offering [Member]
Cash flows from financing activities:
Net proceeds from public placement offering	$ 0	$ 192,156